Unapproved Retatrutide's Black Market Raises Safety Concerns | Retatrutide News

Retatrutide, an unapproved GLP-1 agonist, is reportedly being sold on the black market. This raises safety concerns due to the lack of regulatory oversi...
Market News · October 25, 2026